Literature DB >> 7733768

Neurologic complications of coronary artery bypass grafting: diffuse or focal ischemia?

M J Harrison1.   

Abstract

The central nervous system complications arising during or shortly after coronary artery bypass grafting are due to cerebral ischemia associated with hypotension and to embolism. Hemodynamic compromise produces a spectrum of disturbance of consciousness and mentation ranging from brain death and coma through the chronic vegetative state to mild confusion. Watershed infarction may add to this picture focal deficits such as visual disorientation and cortical field defects or bibrachial weakness (the "man in a barrel" syndrome). Macroembolism accounts for most perioperative strokes and is related to cardiac arrhythmias, to intracardiac thrombus, and particularly to the severity and friable nature of any aortic atheroma. Microembolism can cause focal problems in the watershed territory but is normally responsible for diffuse changes as seen in the neuropsychologic sequelae of coronary artery bypass grafting. Coexistent carotid artery disease rarely contributes to the postoperative neurologic changes.

Entities:  

Mesh:

Year:  1995        PMID: 7733768     DOI: 10.1016/0003-4975(95)00056-q

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  4 in total

1.  Hypopituitarism after coronary artery bypass grafting.

Authors:  J S Davies; M F Scanlon
Journal:  BMJ       Date:  1998-02-28

2.  Seizures Following Cardiopulmonary Bypass.

Authors:  Monique E Brouwer; William J McMeniman
Journal:  J Extra Corpor Technol       Date:  2016-09

3.  Forebrain ischemia triggers GABAergic system degeneration in substantia nigra at chronic stages in rats.

Authors:  B Lin; S Levy; A P Raval; M A Perez-Pinzon; R A Defazio
Journal:  Cardiovasc Psychiatry Neurol       Date:  2010-10-14

Review 4.  Addressing the Global Burden of Trauma in Major Surgery.

Authors:  Geoffrey P Dobson
Journal:  Front Surg       Date:  2015-09-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.